Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation

Science. 2016 May 27;352(6289):aad7993. doi: 10.1126/science.aad7993. Epub 2016 Apr 28.

Abstract

The host innate immune response is the first line of defense against pathogens and is orchestrated by the concerted expression of genes induced by microbial stimuli. Deregulated expression of these genes is linked to the initiation and progression of diseases associated with exacerbated inflammation. We identified topoisomerase 1 (Top1) as a positive regulator of RNA polymerase II transcriptional activity at pathogen-induced genes. Depletion or chemical inhibition of Top1 suppresses the host response against influenza and Ebola viruses as well as bacterial products. Therapeutic pharmacological inhibition of Top1 protected mice from death in experimental models of lethal inflammation. Our results indicate that Top1 inhibition could be used as therapy against life-threatening infections characterized by an acutely exacerbated immune response.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Azepines / pharmacology
  • Azepines / therapeutic use
  • Camptothecin / pharmacology
  • Camptothecin / therapeutic use
  • DNA Topoisomerases, Type I / metabolism*
  • Ebolavirus
  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use
  • Gene Expression Regulation / drug effects*
  • HEK293 Cells
  • Hemorrhagic Fever, Ebola / drug therapy
  • Host-Pathogen Interactions / drug effects
  • Host-Pathogen Interactions / genetics*
  • Humans
  • Immunity, Innate
  • Inflammation / drug therapy*
  • Inflammation / genetics*
  • Inflammation / microbiology
  • Influenza A virus
  • Interferon-beta / immunology
  • Mice
  • Mice, Inbred C57BL
  • Piperidines / pharmacology
  • Piperidines / therapeutic use
  • Positive Transcriptional Elongation Factor B / antagonists & inhibitors
  • RNA Polymerase II / metabolism
  • Sendai virus
  • Staphylococcal Infections / drug therapy
  • Staphylococcus aureus
  • Topoisomerase I Inhibitors / pharmacology
  • Topoisomerase I Inhibitors / therapeutic use*
  • Topotecan / therapeutic use
  • Transcription, Genetic / drug effects*
  • Triazoles / pharmacology
  • Triazoles / therapeutic use

Substances

  • (+)-JQ1 compound
  • Azepines
  • Flavonoids
  • Piperidines
  • Topoisomerase I Inhibitors
  • Triazoles
  • alvocidib
  • Interferon-beta
  • Topotecan
  • Positive Transcriptional Elongation Factor B
  • RNA Polymerase II
  • DNA Topoisomerases, Type I
  • Camptothecin